| scholarly article | Q13442814 |
| P50 | author | Gaia Faustini | Q59568327 |
| Arianna Bellucci | Q59568334 | ||
| Francesca Longhena | Q88924449 | ||
| P2093 | author name string | Cristina Missale | |
| Marina Pizzi | |||
| P2860 | cites work | The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia | Q22252705 |
| Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease | Q24299645 | ||
| Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress | Q24320119 | ||
| Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain | Q24321216 | ||
| Mechanisms of dopamine transporter regulation in normal and disease states | Q24598750 | ||
| α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies | Q24653247 | ||
| The Synaptic Function of α-Synuclein | Q27694711 | ||
| Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system | Q28594502 | ||
| Direct observation of individual endogenous protein complexes in situ by proximity ligation | Q29616032 | ||
| Phosphorylated α-synuclein in Parkinson's disease | Q30510167 | ||
| Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. | Q33941736 | ||
| SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease | Q33944220 | ||
| alpha-Synuclein is phosphorylated in synucleinopathy lesions | Q34111460 | ||
| Attenuation of dopamine transporter activity by alpha-synuclein | Q34187960 | ||
| Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease | Q34673305 | ||
| Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases | Q35346723 | ||
| α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. | Q35626155 | ||
| Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons | Q35807528 | ||
| Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats. | Q36172332 | ||
| Dopamine Transporter Activity Is Modulated by α-Synuclein. | Q36444116 | ||
| Structural and functional properties of prefibrillar α-synuclein oligomers | Q36796130 | ||
| Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner | Q36887384 | ||
| Disease duration and the integrity of the nigrostriatal system in Parkinson's disease | Q37043102 | ||
| Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. | Q37677837 | ||
| Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease. | Q37737032 | ||
| Synuclein modulation of monoamine transporters | Q37852164 | ||
| Novel Strategies for Drug Discovery Based on Intrinsically Disordered Proteins (IDPs) | Q37891686 | ||
| The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues | Q38306271 | ||
| Review: Parkinson's disease: from synaptic loss to connectome dysfunction. | Q38650395 | ||
| Intracellular Dynamics of Synucleins: "Here, There and Everywhere". | Q38651392 | ||
| The clathrin-dependent localization of dopamine transporter to surface membranes is affected by α-synuclein | Q39094270 | ||
| Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter | Q40363580 | ||
| α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons | Q42476891 | ||
| Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein. | Q42483202 | ||
| The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging. | Q42700405 | ||
| Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation | Q44632120 | ||
| Nigral burden of alpha-synuclein correlates with striatal dopamine deficit | Q46467299 | ||
| Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease | Q46593989 | ||
| Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases | Q47720283 | ||
| Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains | Q47866245 | ||
| Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease | Q48268875 | ||
| Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. | Q48586171 | ||
| Immunochemical analysis of dopamine transporter protein in Parkinson's disease | Q48742316 | ||
| Effects of exogenous alpha-synuclein on stimulated dopamine overflow in dorsal striatum | Q49051594 | ||
| Nigrostriatal dopamine transporter availability in early Parkinson's disease | Q50047313 | ||
| Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. | Q51732455 | ||
| In Situ Proximity Ligation Assay Reveals Co-Localization of Alpha-Synuclein and SNARE Proteins in Murine Primary Neurons | Q52330497 | ||
| Extreme disorder in an ultrahigh-affinity protein complex. | Q52375447 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | putamen | Q550934 |
| Parkinson's disease | Q11085 | ||
| Synuclein | Q24767155 | ||
| P304 | page(s) | 1611 | |
| P577 | publication date | 2018-05-30 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study | |
| P478 | volume | 19 |
| Q89251186 | Is Braak staging valid for all types of Parkinson's disease? |
| Q97519880 | KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson's Disease |
| Q60922145 | Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology |
| Q92150656 | Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay |
Search more.